Sushma Yadav

Title: Sushma Yadav: Innovator in Pancreatic Beta Cell Viability

Introduction

Sushma Yadav is a prominent inventor based in Duarte, CA (US). She has made significant contributions to the field of medical science, particularly in improving pancreatic beta cell viability. With a total of 3 patents, her work focuses on innovative methods to treat diseases related to beta cell destruction.

Latest Patents

One of her latest patents involves methods, compositions, and kits for improving pancreatic beta cell viability and treating diseases or conditions related to beta cell destruction. This patent provides novel methods for increasing β-cell viability in islets by delivering RLIP76 polypeptides or GSTA4 polypeptides, or a combination thereof. Additionally, it includes RLIP76 polynucleotides or GSTA4 polynucleotides, or a combination thereof, to the islets. The disclosure also outlines methods for treating conditions such as type 1 diabetes mellitus by delivering these polypeptides or polynucleotides to islets and subsequently transplanting the islets into the subject. Furthermore, kits and compositions that include these polypeptides or polynucleotides are provided to enhance β-cell viability.

Career Highlights

Sushma has worked with notable organizations such as City of Hope and the University of Texas System. Her experience in these institutions has allowed her to collaborate with leading experts in her field and contribute to groundbreaking research.

Collaborations

Some of her notable coworkers include Sanjay Awasthi and Sharad S Singhal. Their collaborative efforts have further advanced the research and development of innovative solutions in the medical field.

Conclusion

Sushma Yadav's work in improving pancreatic beta cell viability showcases her dedication to advancing medical science. Her innovative patents and collaborations highlight her significant impact in the field.